Immunogenicity of Idursulfase and Clinical Outcomes in Very Young Patients (16 Months to 7.5 Years) With Mucopolysaccharidosis II (Hunter Syndrome)

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-015-0265-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search